Introduction {#s1}
============

Autophagy is a highly regulated lysosomal degradation process by which intracellular components are degraded and recycled for cell viability and homeostasis. There is increasing evidence of the importance of autophagy in a variety of physiological and pathological processes, including differentiation, development, aging, and tumorigenesis ([@bib20]; [@bib41]). The autophagic pathway is controlled by a series of evolutionarily conserved autophagy-related (Atg) proteins to generate double-membraned vesicles, the autophagosomes, which subsequently fuse with lysosomes for the degradation of their contents ([@bib11]). Atg9 is the only multi-spanning transmembrane protein in the family and is involved in promoting lipid transport to autophagosomes during their formation ([@bib66]; [@bib71]). In yeast, distinct from other Atg proteins, Atg9 cycles between cytoplasmic membrane pools and the preautophagosomal structure (PAS) ([@bib34]). The Atg9-containing vesicles are recruited to PAS by the Atg1-kinase complex during autophagosome formation ([@bib50]; [@bib62]). Similarly, mammalian Atg9 (mAtg9) localizes to the trans-Golgi network, endosomal system, and plasma membrane under normal conditions, whereas it translocates to autophagic membranes upon autophagy induction ([@bib45]; [@bib47]; [@bib48]; [@bib72]). The trafficking of mAtg9 is important for autophagy induction, and several proteins, including Ulk1, ZIPK, p38IP, TRAPPC8, TBC1D5, and the AP2 complex ([@bib17]; [@bib30]; [@bib47]; [@bib63]; [@bib68]; [@bib72]), regulate the spatio‐temporal distribution of mAtg9 during autophagy.

In addition to autophagy, mAtg9 can modulate dsDNA-induced innate immune responses by regulating the STING-TBK1assembly ([@bib56]). Recently, Imagawa et al showed that mAtg9 also plays a role in necrotic programmed cell death during bone morphogenesis ([@bib16]). Our previous study in *Drosophila* showed that Atg9 functions not only as an essential component of autophagy, but also interacts with *Drosophila* tumor necrosis factor receptor-associated factor 2 (dTRAF2) to regulate ROS-induced c-Jun N-terminal kinase (JNK) signaling, including JNK-mediated autophagy activation and intestinal stem cell (ISC) proliferation ([@bib64]). Moreover, oxidative stress-induced autophagy can inhibit JNK activity through a negative feedback mechanism to prevent the over-activation of JNK-mediated stress responses, thereby helping the maintenance of midgut homeostasis. However, the molecular regulation and physiological function of Atg9 remain largely unknown.

Target of rapamycin (TOR), a serine/threonine kinase, functions as a central player in the regulation of cell growth and metabolism in response to various environmental stimuli, including nutrient status, growth factors, and amino acids ([@bib57]). Under nutrient-rich conditions, TOR promotes protein synthesis and energy metabolism while suppressing autophagy ([@bib55]). Under nutrient deprivation conditions, TOR is inhibited, leading to the induction of autophagy. TOR negatively regulates autophagy by phosphorylating and inhibiting Atg1/Unc51-like kinase 1 (Ulk1) complex activity ([@bib1]). The Atg1/Ulk1 kinase is thought to act as the most upstream autophagy regulator for the initiation of autophagosome formation ([@bib18]). Atg1/Ulk1 recruits downstream Atg proteins to the phagophore assembly site and phosphorylates several Atg proteins, including the Ambra1/Beclin1/Vps34 complex and Atg9 ([@bib6]; [@bib8]; [@bib46]; [@bib54]). Interestingly, recent studies have shown that Atg1/Ulk1 can negatively regulate TOR signaling in *Drosophila* and mammals ([@bib31]; [@bib58]), suggesting a tight interplay between Atg1/Ulk1-dependent autophagy and TOR-mediated cell growth.

Here, we generated null mutants for *Drosophila* Atg9, and showed that loss of *Atg9* severely impairs starvation-induced and developmental autophagy. *Atg9* null mutant flies exhibited dramatically reduced lifespans, climbing defects, and hypersensitivity to stress. Surprisingly, ablation of *Atg9* also caused increased TOR activity and aberrant enlargement of intestinal epithelial cells in the adult *Drosophila* midgut. Similar intestinal defects were observed in *Atg1, Atg13* and *Atg17/Fip200* depletion mutants. We further identified PALS1-associated tight junction protein (Patj) as an Atg9-interacting protein. In mammals, the polarity protein Patj interacts with tuberous sclerosis complex 2 (TSC2), a negative regulator of TOR signaling, to regulate TOR activity ([@bib36]). Strikingly, overexpression of *Patj* and *TSC1-TSC2* suppressed adult midgut defects of *Atg9* mutants. Depletion of *Atg9* resulted in a dramatic decrease in TSC2 levels. Our findings revealed a novel negative feedback loop by which Atg9 inhibits TOR signaling to regulate cell growth and tissue homeostasis.

Results {#s2}
=======

Generation of *Drosophila* Atg9 mutant fly {#s2-1}
------------------------------------------

Our previous studies showed that *Drosophila* Atg9 interacts with dTRAF2 to regulate JNK activation, autophagy induction, and midgut homeostasis under oxidative stress conditions ([@bib64]). To investigate the physiological and developmental functions of Atg9, we generated *Atg9* null mutants using two different approaches. First, we replaced the *Atg9* open reading frame with a Gal4 knock-in cassette (*Atg9^Gal4KO^*) using the ends-out homologous recombination approach ([Figure 1A](#fig1){ref-type="fig"}) ([@bib4]). The Gal4 knock-in can be used for gene expression under *Atg9* endogenous regulatory elements in the *Atg9* mutant background. Second, we employed the CRISPR/Cas9 gene editing approach to replace a short coding region in the first exon of *Atg9* with the attPX-3-frameStop-floxed 3xP3-RFP cassette ([@bib29]), which leads to a pre-maturely truncated *Atg9* mutant (*Atg9^d51^*) ([Figure 1A](#fig1){ref-type="fig"}). The homozygous *Atg9^Gal4KO^* and *Atg9^d51^* flies and trans-heterozygous *Atg9^Gal4KO^/Atg9^d51^* flies are semi-lethal, with a few escapers. Interestingly, the escapers produce no offspring, suggesting fertility defects in *Atg9* mutants. We next compared Atg9 expression in wild-type and mutant flies. We confirmed the lack of Atg9 expression in the mutants by RT-PCR and Western blot analysis ([Figure 1B and C](#fig1){ref-type="fig"}). Importantly, the gene expression and semi-lethality of *Atg9* mutants can be fully rescued by a 5.8 kb genomic construct encompassing the *Atg9* transcript and its endogenous regulatory regions ([Figure 1A--C](#fig1){ref-type="fig"}). These results demonstrated that *Atg9^Gal4KO^* and *Atg9^d51^* specifically disrupt Atg9 function and act as null mutants.

![Generation of mutations in *Drosophila Atg9*.\
(**A**) Schematic view of *Atg9^Gal4KO^* and *Atg9^d51^*mutations relative to the *Atg9* transcripts. For the *Atg9^Gal4KO^* mutation, the complete *Atg9* open reading frame was replaced with a Gal4 knock-in cassette. For *Atg9^d51^* mutation, the 52--102 bp after the *Atg9* start codon was replaced with the attPX-3-frameStop-floxed 3xP3-RFP cassette. (**B**) RT-PCR analysis of *Atg9* mRNA expression level in control, mutant and *Atg9* genomic rescue adult flies. *Atg9* mRNA levels were undetectable in the *Atg9* mutant. (**C**) Western blots show the endogenous Atg9 protein in control and *Atg9* genomic rescue flies but fail to detect the protein in mutants. (**D**) LysoTracker Green staining reveals that starvation-induced autophagy is strongly reduced in *Atg9* mutant fat bodies, compared with controls. Scale bar: 5 μm. (**E**) Quantification of data shown in (**D**). n ≥ 10, data are mean ±s.e.m. \*p\<0.05, \*\*p\<0.01. ns, not statistically significant. (**F**) Western blots show markedly increased Ref(2)P and ubiquitinated protein levels in *Atg9* mutants. (**G**) Immunostaining of *Drosophila* thoracic muscles with anti-Ub (FK2) and anti-Ref(2)p antibodies showed an accumulation and colocalization of polyubiquitin protein aggregates and Ref(2)p (arrowheads) in *Atg9* mutant flies. Scale bar: 10 μm. *Df* refers to *Df(2R)Exel7142*, which removes *Atg9* and flanking genes.\
10.7554/eLife.29338.004Figure 1---source data 1.Quantification of lysotracker dots.](elife-29338-fig1){#fig1}

*Atg9* mutants have impaired autophagy and increased ubiquitination {#s2-2}
-------------------------------------------------------------------

RNAi-mediated knockdown of *Atg9* inhibits starvation-induced autophagy and developmental autophagy in the larval fat body ([@bib3]; [@bib64]). To determine whether the newly generated *Atg9* null mutants also exhibit autophagic defecs, we first stained the larval fat body with the pH-sensitive fluorescent dye LysoTracker, which has been widely used to detect acidic lysosomes and autolysosomes. The LysoTracker Green staining was faint and diffuse in well fed control animals, whereas nutrient deprivation resulted in a strong punctate LysoTracker Green staining ([Figure 1D](#fig1){ref-type="fig"}). Notably, loss of *Atg9* dramatically blocked the starvation-induced punctate staining, compared to the controls ([Figure 1E](#fig1){ref-type="fig"}). Because inhibiting autophagic activity often results in the accumulation of autophagic substrate p62/SQSTM1 and ubiquitinated protein aggregates ([@bib28]), we investigated the effect of Atg9 on protein ubiquitination and autophagic degradation of Ref(2)P, the *Drosophila* homolog of p62. Compared to the control, *Atg9* mutants had a dramatic increase in Ref(2)p levels and ubiquitin aggregate formation ([Figure 1F and G](#fig1){ref-type="fig"}). Moreover, *Atg9* null mutants displayed impaired developmental autophagy in the larval fat body and larval midgut ([Figure 1---figure supplement 1A and B](#fig1s1){ref-type="fig"}). These results together demonstrate the essential role of Atg9 in autophagy during development and in response to starvation.

*Atg9* mutants exhibit shortened lifespan, locomotor defects, and increased susceptibility to stresses {#s2-3}
------------------------------------------------------------------------------------------------------

Many *Drosophila* autophagy mutants display reduced lifespan and decreased climbing activity ([@bib23]; [@bib27]). To gain more insight in the physiological function of Atg9, we analyzed the effect of *Atg9* gene ablation on the lifespan of *Drosophila*. As shown in [Figure 2A](#fig2){ref-type="fig"}, we found that the lifespan of *Atg9* mutants was greatly reduced compared with that of *Atg9* heterozygous control flies (48% decrease in male mean lifespan and 53% in female, p\<0.001) or *Atg7* mutants (38% decrease in male mean lifespan and 40% in female, p\<0.001) under normal conditions. The negative geotaxis assay also revealed that *Atg9* mutants exhibited a significantly lowered climbing activity than that of the control flies ([Figure 2B](#fig2){ref-type="fig"}). The locomotion defects of *Atg9* mutants were substantially suppressed by expressing the *Atg9* genomic rescue construct, suggesting that the mobility defects were indeed caused by interruption of *Atg9* gene expression. Moreover, loss of *Atg9* leads to dramatically decreased viability under starvation and oxidative stress conditions ([Figure 2C,D](#fig2){ref-type="fig"}). We thus conclude that, like other autophagy mutants, Atg9 also regulates *Drosophila* lifespan, mobility, and susceptibility to stresses.

![The *Atg9* mutant flies display shortened lifespan, locomotor defects and decreased stress tolerance.\
(**A**) Both *Atg7* and *Atg9* mutant flies showed shortened lifespan compared with control (Log-rank test, p\<0.001). Comparing with *Atg7* mutant, *Atg9* mutant flies exhibited dramatically shortened lifespan. (**B**) Climbing analysis showed that *Atg9* mutant exhibit decreased climbing activity in both male and female flies, compared with controls (\*\*\*p\<0.001). The locomotion defects can be rescued by expressing the *Atg9* genomic rescue construct. (**C--D**) Both male and female *Atg9* mutant flies die faster than control flies under complete starvation conditions (Log-rank test, p\<0.001) or on paraquat treatment (Log-rank test, p\<0.001).\
10.7554/eLife.29338.007Figure 2---source data 1.Survival rate and climbing activity of control and *Atg9 *mutants.](elife-29338-fig2){#fig2}

Atg9 is required for proper adult midgut morphogenesis {#s2-4}
------------------------------------------------------

The *Drosophila* adult midgut shares many similarities with the mammalian intestine and has emerged as an attractive model system to study stem cell proliferation and differentiation ([@bib19]). Our previous study showed that *Drosophila* Atg9 is involved in regulating adult midgut homeostasis upon ROS stimulation and bacterial infection ([@bib64]). To examine whether Atg9 has a function in maintaining intestinal homeostasis under normal conditions, we examined the adult midgut morphology of the *Atg9* mutant. The *Drosophila* adult midgut consists of a tubular, monolayered epithelium surrounded by visceral muscles ([@bib38]). In striking contrast, the *Atg9* mutant adult midgut is markedly shortened and significantly thickened in the posterior region, compared to control flies ([Figure 3A](#fig3){ref-type="fig"}). Moreover, phalloidin staining of actin filaments in the visceral muscles revealed a severe disruption in the continuity of the visceral mesoderm layer surrounding the gut ([Figure 3B](#fig3){ref-type="fig"}). To assess whether the loss of *Atg9* would affect intestinal barrier function, we examined the intestinal integrity by feeding flies of different ages with a nonabsorbable blue food dye ([@bib51]). As expected, the dye was restricted to the digestive tract in young control flies (10 days, Smurf- fly), whereas the dye was seen throughout the body in approximately 7% of the aged control flies (30 days, Smurf + fly) due to a loss of intestinal integrity ([Figure 3---figure supplement 1A and B](#fig3s1){ref-type="fig"}). Although we found no significant intestinal barrier dysfunction in young *Atg9* mutants, there was a dramatic increase of Smurf + flies in aged *Atg9* mutant animals, compared to controls ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}).

![Atg9 is required for adult *Drosophila* midgut morphogenesis.\
(**A**) *Atg9* mutant midguts are shortened and display enlargement in the posterior region (arrow). Scale bar: 500 μm. Quantification of adult midgut length and posterior midgut width of control and *Atg9* mutant flies. n = 10, \*\*p\<0.01. (**B**) Phalloidin staining of midgut visceral muscles revealed that loss of *Atg9* leads to disruption of actin filaments. Scale bar: 20 μm. (**C--D**) Optical sections of control and the *Atg9* mutant midgut epithelium layer stained with anti-Dlg showing that *Atg9* mutants display abnormally enlarged cells with apical protrusions (arrowheads) into the lumen. Scale bar: 20 μm. (**E**) Quantification of cell size (shown in panel C) in control and *Atg9* mutant posterior midgut. n ≥ 25, \*p\<0.05, \*\*p\<0.01. (**F**) Quantification of phospho-Histone3 positive (PH3^+^) cells per midgut of control and *Atg9* mutant flies at 5 days and 30 days of age. n ≥ 8. (**G**) Quantification of total midgut cell numbers, posterior midgut ISC (Delta^+^) and EE (Pros^+^) cell numbers of 5-day-old control and *Atg9* mutant adults. n ≥ 10. Data are mean ±s.e.m. ns, not statistically significant.\
10.7554/eLife.29338.010Figure 3---source data 1.Quantification of midgut length and width, cell size, total cell number, and PH3+, Delta+, Pros+ cells per gut.](elife-29338-fig3){#fig3}

The *Drosophila* adult midgut epithelium homeostasis is maintained by self-renewing intestinal stem cells (ISC) that divide asymmetrically to generate renewed ISCs and enteroblasts (EB) ([@bib38]; [@bib43]). The EB further differentiate into either absorptive enterocytes (EC) or secretory enteroendocrine cells (EE). In wild-type or *Atg9* heterozygous mutant flies, the intestinal epithelium consistently showed a tight, polarized monolayer ([Figure 3C,D](#fig3){ref-type="fig"}). In *Atg9* mutant flies, the epithelium was also a monolayer, but composed of dramatically enlarged cells and abnormal apical membrane protrusions that often expanded into the midgut lumen ([Figure 3C--E](#fig3){ref-type="fig"}). Notably, the aberrant midgut defects in *Atg9* mutants can be fully rescued by the *Atg9* genomic transgene ([Figure 3C--E](#fig3){ref-type="fig"}), further demonstrating that the intestinal defects were a direct consequence of the *Atg9* mutation.

To investigate whether the aberrant posterior midgut enlargement in *Atg9* mutants was due to an increase in cell growth and proliferation, we measured the ISC mitotic index in the *Atg9* mutant adult midgut. Immunostaining with an antibody for the mitotic marker phospho*-*histone 3 (PH3) in the whole midgut revealed no statistical difference in the number of PH3-positive cells between *Atg9* null and control flies at both 5 days and 30 days of age ([Figure 3F](#fig3){ref-type="fig"}). Moreover, the *Atg9* mutant midgut showed a similar number of total intestinal cells, Delta-positive (ISC-specific marker) cells and Pros-positive (EE marker) cells, compared with controls ([Figure 3G](#fig3){ref-type="fig"}). Together, these results indicate that Atg9 is not required for the regulation of ISC proliferation under normal conditions.

Atg9 acts in ECs to regulate cell growth {#s2-5}
----------------------------------------

To gain insights on the cell type requirement of Atg9 function, we expressed *Atg9^RNAi^* with *Dl-Gal4* driver in ISCs, *Su(H)GBE-Gal4* in EBs, and *Myo1A-Gal4* (*NP1-Gal4*) in ECs. While *Atg9* depletion in ISCs and EBs did not cause any observable defects in the midgut, *Atg9* depletion in ECs resulted in pronounced defects in the midgut epithelium, with a markedly increased cell size and aberrant cell morphology ([Figure 4A](#fig4){ref-type="fig"}). We further utilized the TARGET system ([@bib37]) to specifically knockdown *Atg9* in adulthood. The negative control was flies maintained at 18°C, and the positive control was flies shifted to 29°C within 24 hr after eclosion to inactivate Gal80^ts^ and enable expression of the RNAi targeting *Atg9* gene. Because the midgut defects was only observed when *Atg9^RNAi^* was induced by temperature shift in adult flies with *Tub-Gal4; Tub-Gal80^ts^* as driver, the aberrant midgut enlargement is likely not caused by defects during development ([Figure 4B](#fig4){ref-type="fig"}). Moreover, although the visceral muscle defects were observed in *Atg9* mutants ([Figure 3B](#fig3){ref-type="fig"}), we found that, like *Atg9* depletion in ISCs and EBs, ablation of *Atg9* with muscle-specific *How-Gal4^ts^* did not cause any observable defects in the adult midgut ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). To further explore the role of Atg9 in adult midguts, we generated *Atg9* mitotic clones using the heat shock-inducible Flp*-*FRT system. Mosaic analysis of *Atg9* mutant clones revealed a dramatic increase in cell size of *Atg9* mutant cells ([Figure 4C](#fig4){ref-type="fig"}, GFP-negative, encircled). Next, we utilized the MARCM (mosaic analysis with a repressible cell marker) technique to generate clones of cells homozygous for the *Atg9* mutation ([Figure 4D](#fig4){ref-type="fig"}, marked by GFP). Immunostaining with Pdm1 (an EC specific marker) ([@bib32]) revealed that many of the enlarged GFP-positive cells in *Atg9* mutant clone were stained positive for Pdm1 ([Figure 4D](#fig4){ref-type="fig"}), suggesting that Atg9 acts largely in ECs to regulate cell growth.

![Loss of *Atg9* leads to enlarged enterocytes.\
(**A**) Expression *Atg9^RNAi^* in ISCs, EBs and ECs with *Dl-Gal4*, *Su(H)GBE-Gal4*, or *NP1-Gal4*, respectively. Ablation of *Atg9* in ECs, but not ISCs or EBs, caused enlarged cell size. n ≥ 25, \*\*\*p\<0.001. (**B**) Temporal control of *Atg9^RNAi^* expression using the *Gal80^ts^; Tub-Gal4* inducible system. The flies were either maintained at 18°C throughout development or shifted to 29°C after eclosion for 5 days to inactivate *Gal80^ts^* and enable expression of the RNAi targeting *Atg9*. (**C**) Clonal analysis in adult midgut using Flp-FRT-mediated recombination revealed that *Atg9^d51^* mutant cells (marked by lack of GFP and Atg9 expression) are larger than the controls (GFP-positive cells). n ≥ 17, \*\*\*p\<0.001. (**D**) MARCM analysis showed that the enlarged *Atg9^d51^* mutant cells (marked by GFP) are Pdm1 positive EC cells. n ≥ 21, \*\*\*p\<0.001. Scale bar: 20 μm. Genotypes: (**C**) *hsFLP; FRT42D Ubi-GFP/FRT42D Atg9^d51^* (**D**) *hsFLP; FRT42D tubGal80/FRT42D Atg9^d51^; Tub-Gal4/UAS-mCD8GFP*.\
10.7554/eLife.29338.015Figure 4---source data 1.Quantification of cell size.](elife-29338-fig4){#fig4}

To investigate the involvement of other *Drosophila Atg* genes in midgut cell growth and homeostasis, we systematically depleted *Atg1*, *Atg13*, *Atg17/FIP200*, *Atg9*, *Atg7*, *Atg12*, *Atg16*, *Atg18*, and *Vps34* with *NP1-Gal4; tubulin-Gal80^ts^* as driver. Surprisingly, only RNAi targeting *Atg9* and components of the Atg1 kinase complex, but not other *Atg* genes, caused prominent defects in the midgut epithelium ([Figure 5A,B](#fig5){ref-type="fig"}). Similar to the *Atg9* mutant, depletion of *Atg1*, *Atg13*, and *Atg17* showed enlarged and disorganized midgut epithelial cells. Moreover, we found that knockdown of *Atg1*, *Atg13*, and *Atg17* in the adult fly also caused intestinal barrier dysfunction and shortened lifespan ([Figure 5---figure supplement 1A and B](#fig5s1){ref-type="fig"}). We further confirmed that autophagy activity is efficiently blocked by temporal knockdown of these *Atg* genes ([Figure 5---figure supplement 2A and B](#fig5s2){ref-type="fig"}). Studies in yeast have shown that Atg9 is a direct target of Atg1 kinase during early autophagsome formation ([@bib46]). Activation of the Atg1 complex recruits and tethers Atg9-containing vesicles for the initiation of autophagy ([@bib50]). In *Drosophila*, we have previously shown that ablation of *Atg9* suppresses Atg1-induced eye roughness and wing vein defects ([@bib64]). We thus investigated whether Atg1 also genetically interacts with Atg9 in the adult midgut. Indeed, we found that overexpression of *Atg1* can rescue the midgut defects caused by depletion of *Atg9*, whereas *Atg1* depletion enhanced the phenotype ([Figure 5C](#fig5){ref-type="fig"}). These results highlight the critical role of Atg9 and the Atg1 kinase complex in maintaining adult midgut epithelium homeostasis.

![Components of Atg1 kinase complex are required for adult midgut epithelium homeostasis.\
(**A**) Systematic knock-down of *Drosophila Atg1*, *Atg7*, *Atg9*, *Atg12*, *Atg13*, *Atg16*, *Atg17*, *Atg18* and *Vps34* in adult midgut with the EC-specific driver *NP1-Gal4; Gal80^ts^*. The flies were either kept at 18°C throughout development or shifted to 29°C after eclosion for 5 days to inactivate *Gal80^ts^* and enable expression of the RNAi targeting *Atg* genes. Ablation of *Atg1, Atg13,* and *Atg17*, but not other *Atg* genes, caused increased cell size. (**B**) Quantification of posterior midgut cell size (shown in A) of *Atg* depleted flies. n ≥ 15, data are mean ±s.e.m. \*\*p\<0.01, \*\*\*p\<0.001. ns, not statistically significant. (**C**) Overexpression of *Atg1* suppressed *Atg9^RNAi^*-induced adult midgut defects. n ≥ 30, \*\*\*p\<0.001. Scale bar: 20 μm.\
10.7554/eLife.29338.019Figure 5---source data 1.Quantification of cell size.](elife-29338-fig5){#fig5}

Functional interaction between Atg9 and the TOR pathway {#s2-6}
-------------------------------------------------------

The target of rapamycin (TOR) signaling pathway has been shown to regulate cell growth and proliferation ([@bib40]; [@bib75]). TOR is activated by the phosphatidylinositol 3-kinase (PI3K)/AKT pathway in response to nutrients or growth factors such as insulin stimulation ([@bib9]; [@bib44]). The activated TOR kinase phosphorylates ribosomal protein S6 kinase (S6K) and the eukaryotic translation initiation factor 4E-binding protein (4EBP) to regulate protein translation and cell size ([@bib26]). Studies in *Drosophila* and mammals have shown that loss of *Atg1* and *Atg17* can provoke TOR/S6K-dependent cell growth and development ([@bib27]; [@bib31]; [@bib58]). This prompted us to investigate whether TOR signaling is activated in *Atg9* mutants. Intriguingly, Western blot analysis showed a marked increase in S6K and 4EBP phosphorylation levels in the midguts of *Atg9* mutants, compared to controls ([Figure 6A](#fig6){ref-type="fig"}). Inhibition of TOR activity by feeding *Atg9* mutant flies with rapamycin effectively suppressed the enlarged midgut cell size and aberrant epithelial morphology of the *Atg9* mutants ([Figure 6B and C](#fig6){ref-type="fig"}). Moreover, we found that rapamycin treatment significantly rescued the intestinal barrier dysfunction ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}), but not the lifespan defects of *Atg9* mutants ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). We next checked whether modulation of the components of TOR signaling could rescue the Atg9 midgut defects. Overexpression of the TOR negative regulator *TSC1-TSC2* (the tuberous sclerosis complex 1 and 2), the dominant-negative TOR (*TOR^TED^*), the dominant-negative S6K (*S6K^KQ^*), or knockdown of TOR activator Rheb (*Rheb^RNAi^*) strongly suppressed *Atg9^RNAi^*-induced midgut defects ([Figure 6D--H,L](#fig6){ref-type="fig"}). Whereas overexpression of TOR activator *Rheb* or depletion of *TSC1* or *TSC2* enhanced *Atg9^RNAi^*-induced midgut defects ([Figure 6I--K,L](#fig6){ref-type="fig"}). Moreover, ablation of components of the insulin receptor (InR)-PI3K-AKT pathway, which is upstream of TOR, also rescues *Atg9^RNAi^*-induced midgut defects ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). Taken together, these results suggest that Atg9 antagonizes TOR signaling in regulating cell growth and tissue homeostasis in the adult midgut.

![Loss of *Atg9* enhances TOR activity in *Drosophila* adult midgut.\
(**A**) The adult midguts of denoted genotypes were dissected, lysed, and subjected to Western blot analysis with anti-Atg9, anti-Ref(2)P, anti-p-S6K, anti-p-4EBP and anti-tubulin antibodies. (**B**) Inhibition of TOR activity by feeding flies with rapamycin rescued *Atg9* mutant midgut defects. (**C**) Quantification of posterior midgut cell size shown in (**B**). n ≥ 17, data are mean ±s.e.m. \*\*\*p\<0.001. (**D--K**) Atg9 genetically interacts with components of the TOR signaling pathway. The *Atg9^RNAi^*-induced midgut defects (**D**) could be suppressed by the coexpression of *TSC1-TSC2* (**E**), *Rheb^RNAi^* (**F**), dominant-negative TOR (*TOR^TED^*) (**G**), or dominant-negative S6K (*S6K^KQ^*) (**H**), whereas coexpression of TOR activator *Rheb* (**I**) or knock-down of *TSC1* (**J**) or *TSC2* (**K**) could not rescue the *Atg9*^RNAi^-induced midgut defects. Genetic analyses were performed for three times with 100% penetrance of the phenotype. (**L**) Quantification of posterior midgut cell size shown in (**D--K**). n ≥ 18, data are mean ±s.e.m. \*\*\*p\<0.001. ns, not statistically significant. Scale bar: 20 μm.\
10.7554/eLife.29338.025Figure 6---source data 1.Quantification of cell size.](elife-29338-fig6){#fig6}

Atg9 interacts with Patj and TSC2 to regulate midgut cell growth {#s2-7}
----------------------------------------------------------------

To understand the mechanism by which Atg9 negatively regulates TOR signaling and cell growth, we performed a pull down assay using GST-fused C-terminus (residues 668--845) of Atg9 and liquid chromatography-tandem mass spectrometry (LC*-*MS*/*MS) to identity Atg9-interacting proteins. Among the proteins that were identified to interact with Atg9, we focused on Pals1-associated tight junction protein (Patj). While the multi-PDZ domain containing protein Patj forms a complex with the apical polarity protein Crumbs (Crb) and Stardust (Sdt; Pals1), several studies have indicated that Patj is not essential for apical basal polarity in *Drosophila* ([@bib49]; [@bib59]; [@bib76]). In mammals, Patj binds to tight-junction associated proteins such as Pals1, Claudin 1, and ZO-3, and regulates tight junction formation and cell migration ([@bib52]; [@bib61]). Interestingly, recent findings have shown that Patj can interact directly with TSC2 and depletion of Patj leads to increased TOR activity in human intestinal epithelial cells ([@bib36]; [@bib53]), suggesting that Patj may regulate TOR signaling through its interaction with TSC2. We thus performed GST pull-down and co-immunoprecipitation assays to confirm the interaction between Atg9 and Patj. As shown in [Figure 7A](#fig7){ref-type="fig"}, GST-Atg9-C, but not GST, efficiently interacted with Patj. To determine whether full-length Atg9 interacts with Patj, HEK293 cells were transiently transfected with Flag-tagged Atg9 (Flag-Atg9) and Myc-tagged Patj (Myc-Patj). Immunoblotting of the anti-Flag immunoprecipitates from cell lysates showed that Patj co-precipitated with Atg9 ([Figure 7B](#fig7){ref-type="fig"}). Similarly, a reciprocal co-immunoprecipitation experiment with anti-Myc antibody revealed an interaction between Atg9 and Patj ([Figure 7C](#fig7){ref-type="fig"}). Moreover, co-immunoprecipitation assays showed that Patj can interact with TSC2 in *Drosophila* S2 cells ([Figure 7D](#fig7){ref-type="fig"}). We next determined whether Patj could genetically interact with Atg9 in maintaining intestinal homeostasis. Indeed, similar to the *Atg9* mutant, we found that depletion of *Patj* with *NP1-Gal4* results in aberrant intestinal epithelium ([Figure 7E](#fig7){ref-type="fig"}). Overexpression of *Patj* in the midgut largely rescued the *Atg9* depletion-induced midgut defects (60%, n = 24) but not the midgut defects caused by *Atg1* or *Atg17* depletion ([Figure 7F](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1A and B](#fig7s1){ref-type="fig"}), whereas *Patj* depletion exacerbated the midgut defects caused by *Atg9* ablation ([Figure 7F](#fig7){ref-type="fig"}). We have previously shown that ablation of *Atg9* in EC cells leads to increased lethality in response to paraquat ingestion ([@bib64]). Strikingly, ectopic expression of *Patj* in EC cells significantly rescued the paraquat-induced lethality of *Atg9* knockdown animals ([Figure 7---figure supplement 1C](#fig7s1){ref-type="fig"}).

![Atg9 interacts with Patj to regulate midgut cell growth.\
(**A**) Lysates of cells expressing Myc-Patj were incubated with GST or GST--Atg9-C (amino acids 668--845) in GST pull-down assays. The pull-down products and input Myc-Patj were analyzed by Western blots with the anti-Myc antibody. (**B--C**) HEK293T cells transfected with Flag-Atg9 and Myc-Patj were subjected to immunoprecipitation with anti-Flag (**B**) or anti-Myc (**C**) antibody. The immunoprecipitates and total cell lysates (TCL) were analyzed by Western blot with antibodies as indicated. (**D**) S2 cells transfected with pWA-Gal4, pUAS-Flag-TSC2 and pUAS-Myc-Patj were subjected to immunoprecipitation with anti-Flag or anti-Myc antibody. The immunoprecipitates and total cell lysates were analyzed by Western blot with antibodies as indicated. (**E**) Depletion of *Patj* with *NP1-Gal4* resulted in aberrant midgut epithelium and increased EC cell size. n ≥ 34, data are mean ±s.e.m. \*\*\*p\<0.001. (**F**) Patj genetically interacts with Atg9. Overexpression of *Patj* suppressed the *Atg9* depletion-induced midgut defects (60% penetrance, n = 24). The cell size of posterior midgut ECs of each genotype was quantified. n ≥ 20, data are mean ±s.e.m. \*\*\*p\<0.001. Scale bar: 20 μm.\
10.7554/eLife.29338.030Figure 7---source data 1.Quantification of cell size.](elife-29338-fig7){#fig7}

Several studies have shown that TSC2 is a short-lived protein and is readily targeted for degradation ([@bib7]; [@bib15]). We thus investigated whether Atg9 could interact with and regulate TSC2 stability. As shown in [Figure 8A](#fig8){ref-type="fig"}, Atg9 specifically interacted with TSC2 by immunoprecipitation experiments, and depletion of *Atg1* does not affect the association between Atg9, Patj and TSC2 ([Figure 8---figure supplement 1A](#fig8s1){ref-type="fig"}). More strikingly, clonal depletion of *Atg9* (RFP-positive cells) in the adult midgut caused a marked decrease in TSC2 levels ([Figure 8B](#fig8){ref-type="fig"}), whereas TSC2 levels were not affected in *Atg1* or *Atg17* knockdown cells ([Figure 8---figure supplement 1B](#fig8s1){ref-type="fig"}). Immunoblotting analysis showed that TSC2 level is markedly decreased in the midgut of *Atg9* mutants, compared with controls ([Figure 8C](#fig8){ref-type="fig"}). Collectively, our results suggest that Atg9 antagonizes TOR signaling by interacting with Patj-TSC2 and regulates TSC2 stability ([Figure 8D](#fig8){ref-type="fig"}).

![Atg9 interacts with TSC2 to regulate midgut cell growth.\
(**A**) S2 cells transfected with pWA-Gal4, pUAS-Flag-TSC2 and pUAS-GFP-Atg9 were subjected to immunoprecipitation with anti-Flag or anti-GFP antibody. The immunoprecipitates and total cell lysates were analyzed by Western blot with antibodies as indicated. (**B**) Clonal expression of *Atg9^RNAi^* (marked in Red) in the adult midgut resulted in marked decrease in TSC2 levels (green). Line scan across the *Atg9^RNAi^* clone to show the relative fluorescent intensities of TSC2 in control (dsRed-negative) and *Atg9* depletion (dsRed-positive) cells. Scale bar: 5 μm. (**C**) The adult midguts of denoted genotypes were dissected, lysed, and subjected to Western blot analysis with anti-Atg9, anti-TSC2 and anti-tubulin antibodies. N = 3, data are mean ±s.e.m. \*p\<0.05. (**D**) Model for the antagonistic effect of Atg9 on TOR signaling in the regulation of intestinal cell growth and midgut homeostasis in *Drosophila*. Genotypes: (**G**) *hsflp; UAS-Atg9^RNAi^/+; Act-CD2-Gal4-UAS-dsRed.*.\
10.7554/eLife.29338.034Figure 8---source data 1.Quantification of fluorescent intensity and Western blots.](elife-29338-fig8){#fig8}

Discussion {#s3}
==========

In this study, we generated *Drosophila Atg9* null mutants to determine the developmental and physiological function of Atg9. Similar to other autophagy mutants such as *Atg7* and *Atg17/Fip200* null flies ([@bib23]; [@bib27]), *Atg9* mutants exhibit severe defects in *autophagy,* shortened lifespan, impaired motility, and hypersensitivity to stresses. *Atg9* loss-of-function also leads to aberrant midgut enlargement and intestinal barrier dysfunction. Interestingly, we found that, unlike *Atg9* mutant, depletion of *Atg7* in adult flies did not cause aberrant midgut enlargement or intestinal barrier dysfunction ([Figure 5](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). It is possible that the adult midgut defects may contribute to the much shorter lifespan of *Atg9* mutants. Our findings indicate that Atg9 not only acts as a key regulator in autophagy but also functions in maintaining adult *Drosophila* midgut homeostasis.

The *Drosophila* adult midgut is composed of a monolayer of epithelial cells including nutrient absorbing enterocytes (ECs), secretory enteroendocrine (EE) cells, and multipotent intestinal stem cells (ISCs) ([@bib33]). A number of conserved signaling pathways, including insulin, Notch, EGFR, Wingless (Wg)/Wnt, Hippo, TOR, and JAK-STAT pathways, have been shown to be involved in the regulation of ISC proliferation and in the maintenance of tissue homeostasis of the *Drosophila* midgut ([@bib13]; [@bib21]). The enlarged adult midguts observed in *Atg9* mutants may be due to dysregulation of cell proliferation and cell growth. ISCs are the only dividing cells in the *Drosophila* adult midgut and play an essential role in maintaining tissue homeostasis. However, we found that the total number of intestinal cells and Delta^+^ ISC population were not affected in *Atg9* mutants. PH3 staining of control or *Atg9* mutant midguts at young (5 day) or old (30 day) stages showed similar numbers of mitotic ISCs in both animals, thus indicating that loss of *Atg9* does not affect ISC proliferation.

Insulin and TOR signaling are conserved nutrient-sensing pathways involved in regulating cell growth, metabolism and tissue homeostasis ([@bib44]). Recent studies have reported that these pathways regulate enterocyte growth and endoreduplication in the adult *Drosophila* midgut ([@bib2]; [@bib25]; [@bib70]). As the loss of *Atg9* leads to a marked increase in TOR activity, while inhibition of insulin/TOR signaling rescues *Atg9* midgut defects, Atg9 may act as a negative regulator of TOR-mediated cell growth. It is also interesting to note that although *Atg9* depletion caused a dramatic enlargement in adult midgut ECs, we did not find an increase in larval disc cell size ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). It has been shown that the normal development and tissue homeostasis is maintained by a delicate coordination between cell growth and division ([@bib22]; [@bib74]). One possible explanation for this difference is that ECs in adult midgut are non-dividing differentiated cells, whereas larval disc cells are active dividing cells and therefore maintain a moderate cell size.

Besides Atg9, we found that depletion of components of the Atg1 kinase complex also resulted in enlarged adult midgut ECs. While TOR inhibits Atg1/Ulk1-mediated autophagy induction under nutrient-rich conditions, recent reports have shown that Atg1 and Ulk1 negatively regulate TOR signaling in *Drosophila* and mammalian cells, respectively ([@bib31]; [@bib58]). Although Atg9 was found to be a downstream target of Atg1 during autophagy, several lines of evidence suggest that Atg1 inhibits TOR independent of Atg9. First, our genetic results showed that overexpression of *Atg1* rescued *Atg9^RNAi^*-induced midgut defects; in contrast, overexpression of *Atg9* or *Patj* could not suppress the midgut defects caused by *Atg1* depletion ([Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"}). Second, co-immunoprecipitation assays showed that Atg9 can still interact with Patj and TSC2 in *Atg1* knockdown S2 cells ([Figure 8---figure supplement 1A](#fig8s1){ref-type="fig"}). Thirdly, clonal analysis showed that although the TSC2 level was markedly decreased in *Atg9* knockdown cells, TSC2 levels were not affected in *Atg1* or *Atg17* knockdown cells, compared with controls ([Figure 8---figure supplement 1B](#fig8s1){ref-type="fig"}). In mammals, it has been shown that Atg1/Ulk1 inhibits TOR signaling by phosphorylating Raptor and impairs substrate binding to Raptor ([@bib10]; [@bib24]), and the inhibitory effect of Ulk1 on TOR signaling occurred independently of TSC2 ([@bib24]). Our results and findings from mammalian cells together strongly indicate that Atg9 inhibits TOR activity independent of Atg1.

The formation of the midgut epithelium in *Drosophila* depends on the establishment of cell polarity and adhesion ([@bib42]). One striking phenotype observed in *Atg9* mutant midgut epithelium is the appearance of enlarged epithelial cells with aberrant apical membrane expansion. *The Drosophila* epithelial polarity is regulated by evolutionarily conserved polarity protein complexes including the Crumbs (Crb)/Stardust (Sdt)/Patj complex, the Bazooka (Baz)/Par6/aPKC complex and the Scribble/Discs large (Dlg)/Lethal giant larva (Lgl) complex ([@bib65]). While Crumbs and Par complexes are localized apically in epithelial cells for apical domain maintenance, the Scribble complex is localized in the basolateral region for the maintenance of the basolateral membrane. It has been reported that the Par proteins Par3/Baz, Par6, and aPKC are involved in regulating asymmetric cell division and the differentiation of adult *Drosophila* ISCs ([@bib12]). Here, we identified Patj as a novel interactor of Atg9. The scaffolding protein Patj interacts with both Crb-Std and Baz-Std apical polarity protein complexes, and has been shown to play a non-essential role in apical-basal polarity during *Drosophila* development ([@bib49]; [@bib60]; [@bib76]). However, the role of Patj in midgut epithelium formation and the molecular mechanisms underlying Atg9-Patj-TSC2-mediated intestinal cell growth remain unknown. Interestingly, like Atg9, Patj has been shown to cycle between plasma membrane and endosomal compartments in mammalian cells ([@bib14]; [@bib69]). Ablation of *Patj* results in accumulation of Crumbs3 in EEA-1 positive early endosomes ([@bib39]). It will be exciting to determine how Atg9 coordinates with Patj to regulate TSC2 stability and intestinal epithelial homeostasis. Further research should aid our understanding in the regulation of TOR signaling by Atg9 and its role in human diseases.

Materials and methods {#s4}
=====================

*Drosophila* strains and genetics {#s4-1}
---------------------------------

Flies were raised at 25°C following standard procedures unless otherwise noted. The following *Drosophila* strains were used: *Atg7^d14^*, *Atg7^d77^* ([@bib23]), UAS-Atg1 ([@bib58]), *Dl-Gal4*, *Su(H)GBE-Gal4*, ([@bib73]), *How-Gal4^ts^* (gift from Bruno Lemaitre, EPFL), *NP1-Gal4*, UAS-TSC1, UAS-TSC2 ([@bib64]), UAS-Rheb (RRID:[BDSC_9688](https://scicrunch.org/resolver/BDSC_9688)), UAS-S6K^KQ^ (RRID:[BDSC_6911](https://scicrunch.org/resolver/BDSC_6911)), UAS-Tor^TED^ (RRID:[BDSC_7013](https://scicrunch.org/resolver/BDSC_7013)), UAS-Atg1^RNAi^ (RRID:[BDSC_44034](https://scicrunch.org/resolver/BDSC_44034)), UAS-Rheb^RNAi^ (RRID:[BDSC_33966](https://scicrunch.org/resolver/BDSC_33966)), UAS-Atg7^RNAi^ (RRID:[BDSC_34369](https://scicrunch.org/resolver/BDSC_34369)), UAS-Atg9^RNAi^ (RRID:[BDSC_34901](https://scicrunch.org/resolver/BDSC_34901)), UAS-Atg12^RNAi^ (RRID:[BDSC_34675](https://scicrunch.org/resolver/BDSC_34675)), and Df(2R)Exel7142 (RRID:[BDSC_7886](https://scicrunch.org/resolver/BDSC_7886)) flies were obtained from the Bloomington Stock Center; UAS-Patj^RNAi^ (RRID:[FlyBase_FBst0473750](https://scicrunch.org/resolver/FlyBase_FBst0473750)), UAS-Atg13^RNAi^ (RRID:[FlyBase_FBst0475239](https://scicrunch.org/resolver/FlyBase_FBst0475239)), UAS-Atg16^RNAi^ (RRID:[FlyBase_FBst0477819](https://scicrunch.org/resolver/FlyBase_FBst0477819)), UAS-Atg17^RNAi^ (RRID:[FlyBase_FBst0476692](https://scicrunch.org/resolver/FlyBase_FBst0476692)), UAS-Atg18^RNAi^ (RRID:[FlyBase_FBst0477193](https://scicrunch.org/resolver/FlyBase_FBst0477193)), UAS-Vps34^RNAi^ (RRID:[FlyBase_FBst0472170](https://scicrunch.org/resolver/FlyBase_FBst0472170)), UAS-TSC1^RNAi^ (RRID:[FlyBase_FBst0454493](https://scicrunch.org/resolver/FlyBase_FBst0454493)), and UAS-TSC2^RNAi^ (RRID:[FlyBase_FBst0470276](https://scicrunch.org/resolver/FlyBase_FBst0470276)) were obtained from the Vienna *Drosophila* Resource Center.

Generation of *Atg9* mutants {#s4-2}
----------------------------

The *Atg9^Gal4KO^* mutant was generated by knock-in replacement of the *Atg9* genomic region with the Gal4 cassette as described previously ([@bib4]). In brief, we first generated two 500 bp homology arms flanking the 20 kb *Atg9*-containing genomic fragment for first-round recombineering. The following primers were used in a SOEing PCR reaction:

LA500-fwd: 5'-ACAAGTTTGTACAAAAAAGCAGGCT TTGGCAGGCACACGACATTT −3'

LA500-rev: 5'-CACGCAGGATCCCTTCAATCCAGAGCAACAGG-3'

RA500-fwd: 5'-TTGAAGGGATCCTGCGTGGAACCCATCTTTGG-3'

RA500-rev: 5'-ACCACTTTGTACAAGAAAGCTGGGT TTGCATTTTGTTTGCTAAGT −3'

The 1 kb PCR product was then cloned into P\[acman\]-KO to generate P\[acman\]-KO-Atg9-1kb, and the resultant plasmid was digested with BamHI and transformed into DY380 cells containing the *Atg9* genomic DNA. To replace the *Atg9* open-reading frame with the Gal4-RFP-Kan cassette, the following primers were used in second-round recombineering:

Atg9-fwd:5'-TCTCTTAGGAGAGTCAGCTGTTTGCTGAGAAGGTTCAGCAGAATCAAACAACAAAGAATTTTCCAACTTATACTATACAGCGATATAAATAGTCAGAACGGTTGACCTTGACGTTGGGCG-3'

Atg9-rev:5'-GTTTAGCTTAGTTTCAGATTAGTTTAGCTACGCACTAGACGACGTCGTTCGTTCGTTTACACTTTAAAATTTAGGTTAATCACTAATAGCAGAATGGGTGGTCCTTAGCTCTACAGGTGG-3'

The PCR product was transformed into DY380 cells containing P\[acman\]-KO-Atg9-20kb. The transformants containing P\[acman\]-Atg9-Gal4 were PCR-verified followed by sequencing. The confirmed P\[acman\]-Atg9-Gal4 was then injected into the embryo following standard transgenesis protocol. The transgenic *Atg9^Gal4^* allele was then excised in vivo and targeted to the endogenous atg9 locus to generate *Atg9^Gal4KO^* flies.

The *Atg9^d51^* mutant was generated using CRISPR/cas9-based genome editing ([@bib29]). In brief, gRNA sequence GAGGGATGGTGCTCCAGGAA\[CGG\] was cloned into pBFv-U6.3. Cassette attPX-3-frame Stop-floxed 3xP3-RFP flanked by two *Atg9* homology arms (500 bp upstream and downstream of CRISPR targeting site) was cloned into pCR2-TOPO. *Atg9*-targeting gRNA plasmid and donor template for repair were co-injected into embryos of nanos-Cas9 expressing flies. Progeny flies carrying the selection marker of 3xP3-RFP were further validated by genomic PCR and sequencing. The CRISPR-mediated mutagenesis was performed with the help of WellGenetics, Inc. To induce mitotic clones, *hsFLP; FRT42D Ubi-GFP/FRT42D Atg9^d51^* flies were heat shocked in a 37°C water bath for 1 hr twice a day. MARCM clones were generated by placing *hsFLP; FRT42D tubGal80/FRT42D Atg9^d51^; Tub-Gal4/UAS-mCD8GFP* flies in a 37°C water bath for 1 hr twice a day. The flies were kept at 25°C for seven additional days before dissection.

RT-PCR {#s4-3}
------

Total RNA was isolated from adult female flies using TRIzol (Invitrogen). cDNA was synthesized from 1 ug RNA using the Transcriptor First Strand cDNA Synthesis Kit (Roche) according to the manufacturer's instructions. The following pairs of specific primers were used: 5'-TTGTCCAGATCCGAATCCTC-3' (Atg9-L); 5'-TCGTCTGGCTACTTGCCTTT-3' (Atg9-R); 5'-TTGTCTGGGCAAGAGGATCAG-3' (Actin5C-L); 5'-ACCACTCGCACTTGCACTTTC-3' (Actin5C-R).

Plasmids and antibodies {#s4-4}
-----------------------

The pUAS-GFP-Atg9 transgene was generated by PCR amplification Atg9 from RE14003 into the pUAST vector. The Myc-tagged Patj expression plasmid was generated by PCR amplification of Patj from LD22238, then cloned into the pUAST or pcDNA3.1 vector. *Drosophila* pUAS-Flag-TSC2 was kindly provided by Jun Hee Lee (University of Michigan). For the Atg9 genomic rescue construct, the Atg9 genomic locus flanked by 1 kb each of upstream and downstream genomic sequence was cloned into pCaSpeR4. Antibodies used for the study were: anti-Dlg (1:100, DSHB, University of Iowa), anti-Delta (1:100, RRID:[AB_2056641](https://scicrunch.org/resolver/AB_2056641)), and anti-Prospero (1:100, RRID:[AB_528440](https://scicrunch.org/resolver/AB_528440)), anti-Atg9 (1:100) ([@bib64]), anti-TSC2 (1:100, gift from Aurelio Teleman, German Cancer Research Center) ([@bib67]), anti-Pdm1 (1:100, gift from Xiaohang Yang, Zhejiang University), anti-Atg8 (1:100, RRID:[AB_297935](https://scicrunch.org/resolver/AB_297935)), anti-Ref(2)p (1:500, Abcam, Cat\# ab178440), anti-Ub (1:100, RRID:[AB_10691572](https://scicrunch.org/resolver/AB_10691572)), anti-phospho-S6K (1:1000, Cell Signaling, Cat\# 9209), and anti-phospho-4EBP (1:1000, Cell Signaling, Cat\# 2855), anti-GFP (1:100, RRID:[AB_1563142](https://scicrunch.org/resolver/AB_1563142)), anti-Myc (1:500, RRID:[AB_2298152](https://scicrunch.org/resolver/AB_2298152)), anti-PH3 (1:1000, RRID:[AB_477043](https://scicrunch.org/resolver/AB_477043)), anti-Flag (1:1000, RRID:[AB_2687448](https://scicrunch.org/resolver/AB_2687448)), and anti-tubulin (1:5000, RRID:[AB_1844090](https://scicrunch.org/resolver/AB_1844090)).

Cell culture, transfection and immunoprecipitation {#s4-5}
--------------------------------------------------

*Drosophila* S2 cells were cultured at 25°C in Schneider's *Drosophila* medium (Thermo Fisher) containing 10% fetal bovine serum (FBS) and antibiotics. HEK293T cells were cultured at 37°C in Dulbecco's modified Eagle's medium (DMEM) medium (Thermo Fisher) supplemented with 10% FBS and antibiotics. S2 cells were transfected with Lipofectamine 2000 (Invitrogen), whereas HEK293T were transfected with PolyJet (SignaGen) according to the manufacturer\'s protocol. The dsRNAs were generated using the T7 RiboMAX Express RNAi System (Promaga). For immunoprecipitations, cells transiently transfected with the indicated plasmids were scraped from dishes in lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton, 10% glycerol, 1 mM EDTA, 10 mM NaF, 1 mM PMSF, and protease inhibitor cocktail (Roche)). Cell lysates were immunoprecipitated with Myc or Flag antibody at 4°C overnight and protein G-Sepharose beads (GE Healthcare) at 4°C for 1 hr. These beads were washed three times with the lysis buffer.

Immunofluorescence {#s4-6}
------------------

For *Drosophila* midgut immunohistochemistry, female adult midguts were dissected in PBS and immediately fixed in 4% paraformaldehyde for 40 min at room temperature. After fixation, the samples were permeabilized in PBST (PBS containing 0.5% Triton X-100) for 10 min, then blocked in PBST containing 5% Normal Goat Serum (NGS) for 1 hr. The samples were incubated with primary antibodies in PBST-NGS at 4°C for 16 hr. On the following day, samples were washed with PBST and incubated with fluorescent-labeled secondary antibodies at 4°C overnight. Nuclei were stained using DAPI (1 μg/ml). Images were acquired using the Zeiss LSM510 or Olympus FV3000RS confocal laser scanning microscope. For lysotracker staining, *Drosophila* larval fat bodies dissected under fed or starved conditions were incubated for 45 s in 100 μM LysoTracker Green DND-26 (Thermo) with DAPI in PBS, and immediately photographed live on an Olympus BX61 fluorescence microscope.

Lifespan, climbing, and stress resistance analyses {#s4-7}
--------------------------------------------------

The lifespan assays were performed as described previously ([@bib5]). Female or male flies were housed in groups of 20 and the flies were transferred to fresh food every 2--3 days until all were dead. Climbing assays ([@bib35]) and stress resistance experiments were performed as preciously described ([@bib23]; [@bib64]). At least three independent measurements were performed for each experiment.

Rapamycin feeding {#s4-8}
-----------------

Rapamycin feeding was performed as previously described ([@bib2]), with flies being incubated on the food medium containing 50 μM rapamycin (Merck) for 7 days.

Statistical analyses {#s4-9}
--------------------

Statistical analysis was performed by Student's t test. Log-rank test was used for lifespan statistical analysis. Differences were considered significant if p values were less than 0.05 (\*), 0.01 (\*\*), or 0.001 (\*\*\*).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Atg9 antagonizes TOR signaling to regulate intestinal cell growth and epithelial homeostasis in *Drosophila*\" for consideration by *eLife*. Your article has been favorably evaluated by K VijayRaghavan (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The authors report that Atg9 mutant flies show a reduction in lifespan, mobility, and susceptibility to starvation and oxidative stresses. Atg9 mutant flies also show enlarged midgut epithelial cells. Knockdown of Atg1 or Atg17, but not other core Atgs, causes a similar midgut phenotype. The TORC1 pathway is activated in Atg9 mutants because Atg9 interacts with PALS1-associated tight junction protein (Patj) and TSC2 to inactivate TORC1. Pharmacological and genetic inhibition of TOR and overexpression of Patj rescue the midgut phenotype in Atg9 mutants.

Overall, this study is novel and provides new insights into both autophagy and mTOR regulation. The data are mostly convincing and logically explained.

Essential revisions:

1\) It is not completely clear whether the two autophagy factors, Atg9 and Atg1, regulate mTOR independently as shown in [Figure 7H](#fig7){ref-type="fig"}. The following experiments would clarify this issue.

\- Can the midgut phenotype of Atg1 or Atg17 knockdown flies be rescued by overexpression of Patj ([Figure 7E](#fig7){ref-type="fig"})?

\- Is TSC2 unstabilized in Atg1 or Atg17 knockdown flies as in Atg9 knockdown flies ([Figure 7G](#fig7){ref-type="fig"})?

\- Can the Atg9-Ptj-TSC2 form a complex normally in Atg1 knockdown flies?

2\) [Figure 5A and 5B](#fig5){ref-type="fig"}: Is autophagy efficiently blocked by temporal knockdown using the TARGET system. To strengthen the results, the authors should show that autophagic activity is indeed inhibited in these knockdown flies or examine adult midgut in pre-existing mutant flies such Atg7 mutants.

3\) [Figure 7G](#fig7){ref-type="fig"}: Depletion of Atg9 in the adult midgut causes a marked decrease in the TSC2 signal level in immunostaining, but it is not very quantitative. The authors should perform immunoblotting to compare the TSC2 protein level in control and Atg9 mutants, as performed in [Figure 6A](#fig6){ref-type="fig"}.

4\) It remains unclear whether the increased growth of EC in ATG9 mutants is really biologically important. When the increased EC size in ATG9 mutants is rescued (e.g. by TOR inhibition or Patj overexpression in EC cells), are the barrier function and the shortened lifespan restored? These will demonstrate that the increased EC size after a loss of ATG9 is functionally important in affecting the midgut epithelium and lifespan.

5\) Some of the critical data should be quantified (e.g., [Figure 1D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}, [Figure 5C](#fig5){ref-type="fig"}, and [Figure 6B-J](#fig6){ref-type="fig"}) to strengthen this manuscript.

10.7554/eLife.29338.039

Author response

> Essential revisions:
>
> 1\) It is not completely clear whether the two autophagy factors, Atg9 and Atg1, regulate mTOR independently as shown in [Figure 7H](#fig7){ref-type="fig"}. The following experiments would clarify this issue.
>
> \- Can the midgut phenotype of Atg1 or Atg17 knockdown flies be rescued by overexpression of Patj ([Figure 7E](#fig7){ref-type="fig"})?
>
> \- Is TSC2 unstabilized in Atg1 or Atg17 knockdown flies as in Atg9 knockdown flies ([Figure 7G](#fig7){ref-type="fig"})?
>
> \- Can the Atg9-Ptj-TSC2 form a complex normally in Atg1 knockdown flies?

We thank the reviewer for this comment. We have performed several new experiments to demonstrate that Atg9 and Atg1 regulate TOR activity independently. As shown in new [Figure 7---figure supplement 1A-B](#fig7s1){ref-type="fig"}, we found that overexpression of Patj could not rescue the midgut defects caused by Atg1 or Atg17 depletion. Moreover, clonal analysis showed that although the TSC2 level was markedly decreased in Atg9 knockdown cells, TSC2 levels were not affected in Atg1 or Atg17 knockdown cells, compared with controls (new data, [Figure 8---figure supplement 1B](#fig8s1){ref-type="fig"}). Finally, co-immunoprecipitation assays showed that Atg9 can still interact with Patj and TSC2 in Atg1 knockdown S2 cells (new data, [Figure 8---figure supplement 1A](#fig8s1){ref-type="fig"}). In mammals, it has been shown that Atg1/Ulk1 inhibits TOR signaling by phosphorylating Raptor and impairs substrate binding to Raptor (Dunlop et al. 2011, Autophagy and Jung et al. 2011,Autophagy), and the inhibitory effect of Ulk1 on TOR signaling occurred independently of TSC2 (Jung et al. 2011, Autophagy). Our new results and findings from mammalian cells together strongly indicate that Atg9 inhibits TOR activity independent of Atg1.

> 2\) [Figure 5A and 5B](#fig5){ref-type="fig"}: Is autophagy efficiently blocked by temporal knockdown using the TARGET system. To strengthen the results, the authors should show that autophagic activity is indeed inhibited in these knockdown flies or examine adult midgut in pre-existing mutant flies such Atg7 mutants.

We thank the reviewer for this comment. To determine whether autophagy is efficiently blocked by temporal knockdown Atg genes using the TARGET system, we have knocked down Atg genes using *Tub-Gal4^ts^* and checked their effects on starvation-induced autophagy in the larval fat body. The negative control was flies maintained at 18°C, and the positive control was flies shifted to 29°C to inactivate *Gal80^ts^* and enable expression of the RNAi targeting Atg genes. As shown in new [Figure 5---figure supplement 2A-B](#fig5s2){ref-type="fig"}, depletion of Atg1, Atg13, Atg17, Atg7, Atg12, Atg16, Atg18, and Vps34 impaired starvation-induced autophagy. We have previously shown that depletion of Atg9 and Atg12 blocked ROS-induced autophagy in adult midgut (Tang et al. 2013, Dev Cell). Similarly, we found that ROS-induced autophagy is efficiently blocked in the adult midgut of Atg7 mutants ([Author response image 1](#respfig1){ref-type="fig"}).

![Loss of Atg7 impairs paraquat-induced autophagy.\
Adult flies fed with paraquat caused a marked increase of Atg8 puncta formation in midgut cells. Loss of Atg7 or Atg9 resulted in a marked decrease of paraquat-induced Atg8 puncta formation.](elife-29338-resp-fig1){#respfig1}

> 3\) [Figure 7G](#fig7){ref-type="fig"}: Depletion of Atg9 in the adult midgut causes a marked decrease in the TSC2 signal level in immunostaining, but it is not very quantitative. The authors should perform immunoblotting to compare the TSC2 protein level in control and Atg9 mutants, as performed in [Figure 6A](#fig6){ref-type="fig"}.

We thank the reviewer for this comment. We have performed immunoblotting analysis to show that TSC2 level is markedly decreased in the midgut of Atg9 mutants, compared with controls (new data, [Figure 8C](#fig8){ref-type="fig"}).

> 4\) It remains unclear whether the increased growth of EC in ATG9 mutants is really biologically important. When the increased EC size in ATG9 mutants is rescued (e.g. by TOR inhibition or Patj overexpression in EC cells), are the barrier function and the shortened lifespan restored? These will demonstrate that the increased EC size after a loss of ATG9 is functionally important in affecting the midgut epithelium and lifespan.

We thank the reviewer for this comment. Our new data showed that treating flies with TOR inhibitor rapamycin rescues the intestinal barrier defects of Atg9 mutant animals (new data, [Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). Moreover, we have previously shown that ablation of Atg9 in EC cells leads to increased lethality in response to paraquat ingestion (Tang et al. 2013, Dev Cell). Strikingly, ectopic expression of Patj in EC cells significantly rescued the paraquat-induced lethality of Atg9 knockdown animals (new data, [Figure 7---figure supplement 1C](#fig7s1){ref-type="fig"}). These results together strongly suggest that Atg9 is critical for maintaining midgut epithelium function and integrity.

However, we found that rapamycin treatment could not fully rescue the lifespan defects of Atg9 mutants, compared with controls (new data, [Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). It is likely that the additional function of Atg9 may contribute to the shortened lifespan in Atg9 mutant animals.

> 5\) Some of the critical data should be quantified (e.g., [Figure 1D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}, [Figure 5C](#fig5){ref-type="fig"}, and [Figure 6B-J](#fig6){ref-type="fig"}) to strengthen this manuscript.

We have quantified the data in [Figures 1D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}, [Figure 5C](#fig5){ref-type="fig"}, and [Figure 6B-J](#fig6){ref-type="fig"}.
